These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2057665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A, Talal N.
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [Abstract] [Full Text] [Related]

  • 5. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL, Shtutman VZ, Nasonova VA.
    Klin Med (Mosk); 1994 Feb; 72(5):12-9. PubMed ID: 7853807
    [No Abstract] [Full Text] [Related]

  • 6. [Systemic corticosteroid therapy in rheumatology, advantages and risks].
    Gerster JC, So AK, Burckhardt P.
    Praxis (Bern 1994); 1998 Aug 12; 87(33):1024-7. PubMed ID: 9747132
    [Abstract] [Full Text] [Related]

  • 7. Adrenal steroid therapy in neurological disease. Part I.
    Eisen AA, Norris JW.
    Can Med Assoc J; 1969 Jan 04; 100(1):27-30. PubMed ID: 4388115
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy in collagen diseases].
    Brühl W.
    Wiad Lek; 1971 Jul 01; 24(13):1279-83. PubMed ID: 4256585
    [No Abstract] [Full Text] [Related]

  • 9. Corticosteroids for rheumatic disease. 2. Effects on disease states, effects on bone.
    Jamieson T.
    Postgrad Med; 1986 Apr 01; 79(5):247-8, 250. PubMed ID: 3485794
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Serum complement levels in systemic lupus erythematosus].
    Morita M, Nishishita S, Amano T, Ofuji T.
    Arerugi; 1971 Mar 01; 20(3):159-68. PubMed ID: 4101817
    [No Abstract] [Full Text] [Related]

  • 13. Systemic corticosteroid therapy in rheumatic diseases.
    Fries JF, McDevitt HO.
    Ration Drug Ther; 1972 Nov 01; 6(11):1-5. PubMed ID: 4147211
    [No Abstract] [Full Text] [Related]

  • 14. [Our experiences with Imuran treatment].
    Golacka K, Tarka Z.
    Pol Tyg Lek; 1971 Mar 08; 26(10):345-6. PubMed ID: 5550676
    [No Abstract] [Full Text] [Related]

  • 15. [Which anti-inflammatory agents should be used in rheumatology?].
    Gerster JC.
    Schweiz Med Wochenschr; 1981 Feb 21; 111(8):266-71. PubMed ID: 7015496
    [Abstract] [Full Text] [Related]

  • 16. Systemic lupus erythematosus--corticosteroids.
    Kaplan D.
    Clin Rheum Dis; 1983 Dec 21; 9(3):601-16. PubMed ID: 6360515
    [No Abstract] [Full Text] [Related]

  • 17. [Incidence of polymyalgia rheumatica at a department of internal medicine].
    Tamási L, Szegedi G.
    Orv Hetil; 1989 May 21; 130(21):1095-8. PubMed ID: 2660061
    [Abstract] [Full Text] [Related]

  • 18. [Thalidomide--a new prospective therapy in rheumatology and transplantation].
    Pałgan K, Pałgan I, Dziedziczko A.
    Wiad Lek; 2003 May 21; 56(11-12):574-6. PubMed ID: 15058168
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive therapy in management of non-malignant disease.
    Fennelly JJ, Fitzgerald MX, Fitzgerald O.
    J Ir Med Assoc; 1970 Apr 21; 63(394):141-6. PubMed ID: 5418154
    [No Abstract] [Full Text] [Related]

  • 20. The remote effects of rheumatic diseases on the hand, and their management.
    Sturge RA.
    Clin Rheum Dis; 1984 Dec 21; 10(3):449-77. PubMed ID: 6398180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.